HOOKIPA Pharma Q3 EPS $(0.17) Beats $(0.21) Estimate, Sales $6.87M Beat $4.25M Estimate
Portfolio Pulse from Benzinga Newsdesk
HOOKIPA Pharma (NASDAQ:HOOK) reported Q3 earnings per share of $(0.17), beating the analyst consensus estimate of $(0.21) by 19.05%. The company also reported quarterly sales of $6.87 million, surpassing the analyst consensus estimate of $4.25 million by 61.58%. This represents a 32% increase in earnings and a 207.94% increase in sales compared to the same period last year.
November 09, 2023 | 12:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HOOKIPA Pharma's Q3 earnings and sales beat estimates, indicating a positive financial performance. This could potentially lead to a short-term increase in the company's stock price.
HOOKIPA Pharma's better-than-expected Q3 earnings and sales suggest a strong financial performance, which is often a positive signal to investors and could lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100